Alain HORVAIS

Partner in charge of the diagnostics fund, Kurma Life Sciences

  • Research director at Bio-Rad (Paris) for 10 years
  • Director of Companion Diagnostics at Astra Zeneca (UK) for 3 years
  • Specialist of molecular biology and IVD
  • Ph.D in molecular biology and Mastère in management of innovation

« Risks and limits for the industrial development of complex biomarkers »